Pulmonx Corp Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Pulmonx Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2019 to Q3 2024.
  • Pulmonx Corp Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$14.1M, a 5.07% increase year-over-year.
  • Pulmonx Corp Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$57.1M, a 6.75% increase year-over-year.
  • Pulmonx Corp annual Net Income (Loss) Attributable to Parent for 2023 was -$60.8M, a 3.26% decline from 2022.
  • Pulmonx Corp annual Net Income (Loss) Attributable to Parent for 2022 was -$58.9M, a 21.1% decline from 2021.
  • Pulmonx Corp annual Net Income (Loss) Attributable to Parent for 2021 was -$48.7M, a 51% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$57.1M -$14.1M +$756K +5.07% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-01
Q2 2024 -$57.9M -$15.3M +$869K +5.37% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-01
Q1 2024 -$58.7M -$13.7M +$2.11M +13.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-01
Q4 2023 -$60.8M -$13.9M +$395K +2.77% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 -$61.2M -$14.9M -$728K -5.14% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-01
Q2 2023 -$60.5M -$16.2M -$1.56M -10.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-01
Q1 2023 -$59M -$15.9M -$32K -0.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-01
Q4 2022 -$58.9M -$14.3M -$1.28M -9.82% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 -$57.6M -$14.2M -$3.99M -39.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 -$53.7M -$14.6M -$1.68M -12.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-03
Q1 2022 -$52M -$15.8M -$3.32M -26.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-03
Q4 2021 -$48.7M -$13M -$3.71M -39.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-01
Q3 2021 -$45M -$10.2M -$6.32M -164% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$38.6M -$13M -$1.05M -8.82% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-08
Q1 2021 -$37.6M -$12.5M -$5.35M -74.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-08
Q4 2020 -$32.2M -$9.3M -$4.63M -99.1% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-15
Q3 2020 -$27.6M -$3.86M +$475K +11% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$28.1M -$11.9M -$6.34M -114% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-09
Q1 2020 -$21.7M -$7.16M -$1.04M -16.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-09
Q4 2019 -$20.7M -$4.67M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-15
Q3 2019 -$4.34M Jul 1, 2019 Sep 30, 2019 10-K 2021-03-15
Q2 2019 -$5.57M Apr 1, 2019 Jun 30, 2019 10-K 2021-03-15
Q1 2019 -$6.13M Jan 1, 2019 Mar 31, 2019 10-K 2021-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.